Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7707)
All Articles published online
|
Publishing Process of This Article
|
Sep 28, 2014 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Arain A, Robaeys G. Eligibility of persons who inject drugs for treatment of hepatitis C virus infection. World J Gastroenterol 2014; 20(36): 12722-12733 [PMID: 25278674 DOI: 10.3748/wjg.v20.i36.12722] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v20/i36/12722.htm |
| Number | Citing Articles |
| 1 |
James Lara, Mahder A. Teka, Seth Sims, Guo-Liang Xia, Sumathi Ramachandran, Yury Khudyakov. HCV adaptation to HIV coinfection. Infection, Genetics and Evolution 2018; 65: 216 doi: 10.1016/j.meegid.2018.07.039
|
| 2 |
Dana Busschots, Rob Bielen, Özgür M. Koc, Leen Heyens, Eefje Dercon, Rita Verrando, Filip Janssens, Luc Van den Bergh, Peter Van Lint, Liesbeth Bruckers, Frederik Nevens, Geert Robaeys. On-site testing and case management to improve hepatitis C care in drug users: a prospective, longitudinal, multicenter study in the DAA era. BMC Public Health 2021; 21(1) doi: 10.1186/s12889-021-11608-9
|
| 3 |
Annie Pedlar, Prabjot (Jodie) Sandhu. Promoting treatment for hepatitis C in people who inject drugs: A review of the barriers and opportunities. Journal of the American Association of Nurse Practitioners 2020; 32(8): 563 doi: 10.1097/JXX.0000000000000269
|
| 4 |
Jean-Michel Delile, Victor de Ledinghen, Marie Jauffret-Roustide, Perrine Roux, Brigitte Reiller, Juliette Foucher, Daniel Dhumeaux. Hepatitis C virus prevention and care for drug injectors: the French approach. Hepatology, Medicine and Policy 2018; 3(1) doi: 10.1186/s41124-018-0033-8
|
| 5 |
Andrew Radley, Marjon van der Pol, John F Dillon. Application of a discrete choice experiment approach to support the design of a hepatitis C testing service in primary care. International Journal of Drug Policy 2019; 65: 1 doi: 10.1016/j.drugpo.2018.12.008
|
| 6 |
Stella A. Safo, Abigail Batchelder, Deena Peyser, Alain H. Litwin. The common sense model applied to hepatitis C: a qualitative analysis of the impact of disease comparison and witnessed death on hepatitis C illness perception. Harm Reduction Journal 2015; 12(1) doi: 10.1186/s12954-015-0054-1
|
| 7 |
Shari S. Rogal, Rory McCarthy, Andrea Reid, Keri L. Rodriguez, Linda Calgaro, Krupa Patel, Molly Daley, Naudia L. Jonassaint, Susan L. Zickmund. Primary Care and Hepatology Provider–Perceived Barriers to and Facilitators of Hepatitis C Treatment Candidacy and Adherence. Digestive Diseases and Sciences 2017; 62(8): 1933 doi: 10.1007/s10620-017-4608-9
|
| 8 |
Vajiheh Akbarzadeh, Ghina R. Mumtaz, Susanne F. Awad, Helen A. Weiss, Laith J. Abu-Raddad. HCV prevalence can predict HIV epidemic potential among people who inject drugs: mathematical modeling analysis. BMC Public Health 2016; 16(1) doi: 10.1186/s12889-016-3887-y
|
| 9 |
Andrew Radley, Jan Tait, John F. Dillon. DOT-C: A cluster randomised feasibility trial evaluating d irectly o bserved an t i-H C V therapy in a population receiving opioid substitute therapy from community pharmacy. International Journal of Drug Policy 2017; 47: 126 doi: 10.1016/j.drugpo.2017.05.042
|
| 10 |
Brian Conway, Dan Smyth, Réjean Thomas, Alex Wong, Giada Sebastiani, Curtis Cooper, Hemant Shah, Ritesh Kumar, Gretty Deutsch, Ted Watson. Characterizing risk behaviour and reinfection rates for successful programs to engage core transmitters in HCV elimination (C-RESPECT). Canadian Liver Journal 2021; 4(4): 346 doi: 10.3138/canlivj-2021-0005
|
| 11 |
Megan C. Herink, Andrew Seaman, Gillian Leichtling, Jessica E. Larsen, Tonhi Gailey, Ryan Cook, Ann Thomas, P. Todd Korthuis. A randomized controlled trial for a peer-facilitated telemedicine hepatitis c treatment intervention for people who use drugs in rural communities: study protocol for the “peer tele-HCV” study. Addiction Science & Clinical Practice 2023; 18(1) doi: 10.1186/s13722-023-00384-z
|
| 12 |
Heather Valerio, David J. Goldberg, James Lewsey, Amanda Weir, Samuel Allen, Esther J. Aspinall, Stephen T. Barclay, Peter Bramley, John F. Dillon, Ray Fox, Andrew Fraser, Peter C. Hayes, Hamish Innes, Nicholas Kennedy, Peter R. Mills, Adrian J. Stanley, Sharon J. Hutchinson. Evidence of continued injecting drug use after attaining sustained treatment-induced clearance of the hepatitis C virus: Implications for reinfection. Drug and Alcohol Dependence 2015; 154: 125 doi: 10.1016/j.drugalcdep.2015.06.032
|
| 13 |
Hayley Bennett, Jason Gordon, Beverley Jones, Thomas Ward, Samantha Webster, Anupama Kalsekar, Yong Yuan, Michael Brenner, Phil McEwan. Hepatitis C disease transmission and treatment uptake: impact on the cost-effectiveness of new direct-acting antiviral therapies. The European Journal of Health Economics 2017; 18(8): 1001 doi: 10.1007/s10198-016-0844-8
|
| 14 |
Iuliia Makarenko, Adelina Artenie, Stine Hoj, Nanor Minoyan, Brendan Jacka, Geng Zang, Gillian Barlett, Didier Jutras-Aswad, Valerie Martel-Laferriere, Julie Bruneau. Transitioning from interferon-based to direct antiviral treatment options: A potential shift in barriers and facilitators of treatment initiation among people who use drugs?. International Journal of Drug Policy 2019; 72: 69 doi: 10.1016/j.drugpo.2019.04.002
|
| 15 |
Rob Bielen, Christophe Moreno, Hans Van Vlierberghe, Stefan Bourgeois, Jean-Pierre Mulkay, Thomas Vanwolleghem, Wim Verlinden, Christian Brixko, Jochen Decaestecker, Chantal De Galocsy, Filip Janssens, Mike Cool, Lode Van Overbeke, Christophe Van Steenkiste, François D'heygere, Wilfried Cools, Frederik Nevens, Geert Robaeys. Belgian experience with direct acting antivirals in people who inject drugs. Drug and Alcohol Dependence 2017; 177: 214 doi: 10.1016/j.drugalcdep.2017.04.003
|
| 16 |
F. Giudici, B. Bertisch, F. Negro, G. Stirnimann, B. Müllhaupt, D. Moradpour, A. Cerny, O. Keiser. Access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study: a person‐centred approach. Journal of Viral Hepatitis 2016; 23(9): 697 doi: 10.1111/jvh.12535
|
| 17 |
Andrew Radley, Karen Melville, Jan Tait, Brian Stephens, Josie M M Evans, John F Dillon. A quasi-experimental evaluation of dried blood spot testing through community pharmacies in the Tayside region of Scotland. Frontline Gastroenterology 2017; 8(3): 221 doi: 10.1136/flgastro-2016-100776
|
| 18 |
Andrew Radley, Marijn de Bruin, Sarah K Inglis, Peter T Donnan, John F Dillon. Clinical effectiveness of pharmacy-led versus conventionally delivered antiviral treatment for hepatitis C in patients receiving opioid substitution therapy: a study protocol for a pragmatic cluster randomised trial. BMJ Open 2018; 8(12): e021443 doi: 10.1136/bmjopen-2017-021443
|
| 19 |
Omar T. Sims, Quentin R. Maynard, Pam A. Melton. Behavioral Interventions to Reduce Alcohol Use Among Patients with Hepatitis C: A Systematic Review. Social Work in Public Health 2016; 31(6): 565 doi: 10.1080/19371918.2016.1160346
|
| 20 |
N. Beekmans, M. Klemt-Kropp. Re-evaluation of chronic hepatitis B and hepatitis C patients lost to follow-up: results of the Northern Holland hepatitis retrieval project. Hepatology, Medicine and Policy 2018; 3(1) doi: 10.1186/s41124-018-0032-9
|
| 21 |
Chi‐Ming Tai, Yung‐Chieh Yen, Ming‐Jong Bair, Cheng‐Hao Tseng, Ting‐Ting Chang, Chung‐Feng Huang, Ming‐Lun Yeh, Chia‐Yen Dai, Wan‐Long Chuang, Ming‐Lung Yu, Jee‐Fu Huang. Integrated care for methadone maintenance patients with hepatitis C virus infection. The Kaohsiung Journal of Medical Sciences 2019; 35(8): 501 doi: 10.1002/kjm2.12086
|
| 22 |
Nesrin Dilbaz, Murat Kuloğlu, Ekrem Cuneyt Evren, Salih Cihat Paltun, Rabia Bilici, Cemal Onur Noyan, Burak Kulaksizoglu, Vahap Karabulut, Gokhan Umut, Basak Unubol, Enver Ucbilek. HCV Genotype Distribution Among People Who Inject Drug in Turkey: Findings from Multicenter and Cross-Sectional Study. Substance Abuse: Research and Treatment 2023; 17: 117822182311573 doi: 10.1177/11782218231157340
|